BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 38041690)

  • 1. Cuproptosis-related gene
    Deng R; Zhu L; Jiang J; Chen J; Li H
    Biomol Biomed; 2024 May; 24(3):647-658. PubMed ID: 38041690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma.
    Yan C; Niu Y; Ma L; Tian L; Ma J
    J Transl Med; 2022 Oct; 20(1):452. PubMed ID: 36195876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
    Mao M; Wu Z; Chen J
    Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of copper chaperone antioxidant-1 by RNA interference inhibits copper-stimulated proliferation of non-small cell lung carcinoma cells.
    Cai H; Peng F
    Oncol Rep; 2013 Jul; 30(1):269-75. PubMed ID: 23624903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Krüppel-Like Factor 6 Downregulation Is Connected with a Poor Prognosis and Tumor Growth in Non-Small-Cell Lung Cancer.
    Zeng B; Lin J; Cai X; Che L; Zeng W; Liu S
    Comput Math Methods Med; 2022; 2022():3193553. PubMed ID: 35136416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
    Zheng J; Xu T; Chen F; Zhang Y
    Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
    Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
    BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma.
    Zhan ZY; Zhong LX; Feng M; Wang JF; Liu DB; Xiong JP
    Int J Clin Exp Pathol; 2015; 8(5):5080-8. PubMed ID: 26191202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase Recruitment Domain Containing Protein 9 Suppresses Non-Small Cell Lung Cancer Proliferation and Invasion via Inhibiting MAPK/p38 Pathway.
    Pan L; Tan Y; Wang B; Qiu W; Yin Y; Ge H; Zhu H
    Cancer Res Treat; 2020 Jul; 52(3):867-885. PubMed ID: 32164050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
    Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-367 promotes the proliferation and invasion of non-small cell lung cancer via targeting FBXW7.
    Xu J; Wu W; Wang J; Huang C; Wen W; Zhao F; Xu X; Pan X; Wang W; Zhu Q; Chen L
    Oncol Rep; 2017 Feb; 37(2):1052-1058. PubMed ID: 28000899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cuproptosis-Related Genes MTF1 and LIPT1 as Novel Prognostic Biomarker in Acute Myeloid Leukemia.
    Li Y; Kan X
    Biochem Genet; 2024 Apr; 62(2):1136-1159. PubMed ID: 37561332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer.
    Suraweera A; Duff A; Adams MN; Jekimovs C; Duijf PHG; Liu C; McTaggart M; Beard S; O'Byrne KJ; Richard DJ
    Br J Cancer; 2020 Aug; 123(4):591-603. PubMed ID: 32439936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
    Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
    BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RNA-binding protein RBM47 inhibits non-small cell lung carcinoma metastasis through modulation of AXIN1 mRNA stability and Wnt/β-catentin signaling.
    Shen DJ; Jiang YH; Li JQ; Xu LW; Tao KY
    Surg Oncol; 2020 Sep; 34():31-39. PubMed ID: 32891348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revealing prognostic insights of programmed cell death (PCD)-associated genes in advanced non-small cell lung cancer.
    Dong W; Zhang H; Han L; Zhao H; Zhang Y; Liu S; Zhang J; Niu B; Xiao W
    Aging (Albany NY); 2024 May; 16(9):8110-8141. PubMed ID: 38728242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
    Feng A; Tu Z; Yin B
    Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
    Lu YJ; Liu RY; Hu K; Wang Y
    Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of Cuproptosis-Related Genes in Immune Infiltration and Prognosis in Melanoma.
    Lv H; Liu X; Zeng X; Liu Y; Zhang C; Zhang Q; Xu J
    Front Pharmacol; 2022; 13():930041. PubMed ID: 35837286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
    Han Y; Tian H; Chen P; Lin Q
    Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.